HY-131326-100mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-25mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-250mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-50mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-P99175-1mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
HY-P99175-10mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
HY-P99175-5mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
HY-W087027-100mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
HY-W087027-25mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
HY-W087027-50mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
HY-148870-10mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-100mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-25mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-5mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-50mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|